Marcia A. Kean, MBA, has built Feinstein Kean Healthcare’s unique national role in the life sciences since the firm’s inception more than twenty five years ago. She served as the Chief Executive Officer of the firm from 2002 to 2011, and became Chairman, Strategic Initiatives in 2011. Marcia has more than 35 years of biomedical and information technology industry experience. She has business operating experience inside commercial and non-profit organizations, as well as knowledge of the development and implementation of public-private projects undertaken by multi-stakeholder ecosystems. In 2003, Marcia founded the first Molecular Medicine communications practice in the country. She led the communications activities on behalf of the National Cancer Institute’s first-generation bioinformatics program for seven years. Marcia has served as an advisor to the Personalized Medicine Coalition (PMC) since its inception, and as a member of the Planning Committee of the Harvard Personalized Medicine Conference since 2004. She has served as a member of the Evidence Communication Innovation Collaborative of the Institute of Medicine since 2008. She served as co-Vice Chair of the Advisory Committee of the Institute of Medicine’s Cancer Informatics Workshop in February 2012; subsequently, she founded the Data Liquidity Coalition to address the challenges of biomedical data exchange. She chaired the Advisory Committee of “Turning the Tide Against Cancer Through Sustained Medical Innovation”, a national conference on science and policy, co-hosted in June 2012 by the Personalized Medicine Coalition, American Association for Cancer Research, and Feinstein Kean Healthcare. She serves as a member of Life Sciences Research Program Advisory Group of Internet2, and provides input to the Health Data Consortium on policy initiatives and building an ecosystem comprised of multiple constituencies. Marcia holds an M.B.A. in finance from New York University and a B.A. from the University of California at Berkeley.